Ultrasonic surgery specialist Nami Surgical has appointed Nikki Palfrey as CEO raised a £1.9 million from the Investment Fund for Scotland, managed by Maven and delivered by the British Business Bank, alongside existing investors including Eos Advisory and Scottish Enterprise.
The company is targeting the global robotic-assisted surgery market with its pioneering ultrasonic technology, with the funding supporting its transition from advanced development to commercialisation.
Nami develops high‑performance, miniaturised ultrasonic scalpels engineered for seamless integration into articulated, wristed surgical robotic instruments. Its platform is designed to meet the growing demand for advanced tools compatible with next‑generation robotic systems, in a market expected to exceed $25 billion by 2030.
Nikki Palfrey, who has been a Non-executive Director at Nami since 2023, brings over 25 years of leadership experience in the MedTech sector, leading businesses such as Summit Medical and BOWA Medical UK through growth, transformation, and global expansion. As CEO, Palfrey will lead Nami’s commercial strategy and partner engagement as the company progresses towards market entry. Co-founder Nico Fenu moves to the COO role at Nami, the University of Glasgow spinout he founded alongside CTO Rebecca Cleary in 2021.
Rebecca Cleary, Co-founder & CTO, Nico Fenu, Co-founder & COO, and Nikki Palfrey, CEO.
“Nami is exceptionally well positioned to become a leading force in the robotic-assisted surgery market. Building on the strong foundations established by Nico, Rebecca, and the entire team, I am excited to lead the company as we enter an exciting new chapter focused on innovation, scale, and long-term value creation.”
Nikki Palfrey, Nami Surgical CEO
“As founders, Rebecca and I are incredibly proud of how far Nami has come. We are excited about the opportunities ahead in a rapidly growing global market and remain deeply committed to our mission of improving patient outcomes worldwide.”
Nico Fenu, Co-founder and COO of Nami Surgical
"Nami has made great progress since our initial investment in early 2024, and this next phase of commercialising the platform marks an exciting step forward. The business is strategically positioned to drive significant advances in the robotic-assisted surgery market, and the appointment of Nikki as CEO further strengthens the team. We’re delighted to continue supporting the company as it scales."
Victoria McLaren, Investment Manager at Maven
IFS Maven Equity Finance can provide investment of up to £5 million to support ambitious earlier and later stage businesses across Scotland. If your business, or the business you advise, is looking for an equity investment as a solution to fund future growth, get in touch here.